Response Adapted Therapy Using Single Agent Lenalidomide in Older Adults with Newly Diagnosed Standard Risk Multiple Myeloma

被引：0
|
作者：
Baz, Rachid [1 ]
Alsina, Melissa
Shain, Kenneth H. [1 ]
Paleveda, Jennifer [1 ]
Hillgruber, Nancy [1 ]
Finley-Oliver, Elizabeth [1 ]
Ochoa, Leonel
Nishihori, Taiga
Dalton, William [2 ]
Sullivan, Daniel
机构：
[1] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Dept Malignant Hematol, Tampa, FL 33612 USA
[2] Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Personalized Med Inst, Tampa, FL 33612 USA
来源：
BLOOD | 2012年 / 120卷 / 21期
关键词：
D O I：
10.1182/blood.V120.21.4060.4060
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4060
引用
收藏
页数：2
相关论文
共 50 条
  • [41] Thalidomide added to standard therapy improves survival in newly diagnosed multiple myeloma
    不详
    ONCOLOGY-NEW YORK, 2006, 20 (12): : 1486 - 1486
  • [42] Stem cell mobilization in patients with newly diagnosed multiple myeloma after lenalidomide induction therapy
    F Cavallo
    S Bringhen
    G Milone
    D Ben-Yehuda
    A Nagler
    E Calabrese
    N Cascavilla
    V Montefusco
    B Lupo
    A M Liberati
    C Crippa
    F Rossini
    R Passera
    F Patriarca
    A M Cafro
    P Omedè
    A M Carella
    J Peccatori
    L Catalano
    T Caravita
    P Musto
    M T Petrucci
    M Boccadoro
    A Palumbo
    Leukemia, 2011, 25 : 1627 - 1631
  • [43] STEM CELL MOBILIZATION IN PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA FOLLOWING THERAPY WITH LENALIDOMIDE AND DEXAMETHASONE
    Kumar, S.
    Lacy, M. Q.
    Dispenzieri, A.
    Hayman, S. R.
    Dingli, D.
    Miceli, T.
    Litzow, M. R.
    Rajkumar, S. V.
    Gertz, M. A.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2009, 15 (02) : 66 - 66
  • [44] Lenalidomide, bortezomib and dexamethasone induction therapy for the treatment of newly diagnosed multiple myeloma: a practical review
    McCaughan, Georgia J.
    Gandolfi, Sara
    Moore, John J.
    Richardson, Paul G.
    BRITISH JOURNAL OF HAEMATOLOGY, 2022, 199 (02) : 190 - 204
  • [45] Maintenance Therapy With Lenalidomide Significantly Improved Survival Of Yong Newly Diagnosed Multiple Myeloma Patients
    Gay, Francesca
    Cavallo, Federica
    Caravita, Tommaso
    Cavalli, Maide
    Nagler, Arnon
    Montefusco, Vittorio
    Pogliani, Enrico Maria
    Buttignol, Silvia
    Zamagni, Elena
    Palladino, Carmela
    Marcatti, Magda
    Musto, Pellegrino
    Catalano, Lucio
    Baraldi, Anna
    Carella, Angelo Michele
    Afro, Anna Maria
    Siniscalchi, Agostina
    Crippa, Claudia
    Vallone, Letizia Maria
    Ciccone, Giovannino
    Ben Yehuda, Dina
    Di Raimondo, Francesco
    Hardan, Izhar
    Boccadoro, Mario
    Palumbo, Antonio
    BLOOD, 2013, 122 (21)
  • [46] Stem cell mobilization in patients with newly diagnosed multiple myeloma after lenalidomide induction therapy
    Cavallo, F.
    Bringhen, S.
    Milone, G.
    Ben-Yehuda, D.
    Nagler, A.
    Calabrese, E.
    Cascavilla, N.
    Montefusco, V.
    Lupo, B.
    Liberati, A. M.
    Crippa, C.
    Rossini, F.
    Passera, R.
    Patriarca, F.
    Cafro, A. M.
    Omede, P.
    Carella, A. M.
    Peccatori, J.
    Catalano, L.
    Caravita, T.
    Musto, P.
    Petrucci, M. T.
    Boccadoro, M.
    Palumbo, A.
    LEUKEMIA, 2011, 25 (10) : 1627 - 1631
  • [47] Multicenter, phase II study of response-adapted lenalidomide-based therapy for transplant-ineligible patients with newly diagnosed multiple myeloma without high-risk features
    Yoo, Kwai Han
    Yoon, Dok Hyun
    Kang, Hye Jin
    Lee, Won Sik
    Kim, Kihyun
    Kim, Jin Seok
    Kim, Jeong-A
    Kim, Sung-Hyun
    Kwak, Jae-Yong
    Kim, Yang Soo
    Min, Chang-Ki
    Lee, Je-Jung
    Yoon, Sung-Soo
    Suh, Cheolwon
    Baz, Rachid
    Lee, Jae Hoon
    CURRENT PROBLEMS IN CANCER, 2022, 46 (01)
  • [48] Isatuximab, Carfilzomib, Lenalidomide, and Dexamethasone for the Treatment of High-Risk Newly Diagnosed Multiple Myeloma
    Leypoldt, Lisa B.
    Tichy, Diana
    Besemer, Britta
    Haenel, Mathias
    Raab, Marc S.
    Mann, Christoph
    Munder, Markus
    Reinhardt, Hans Christian
    Nogai, Axel
    Goerner, Martin
    Ko, Yon-Dschun
    de Wit, Maike
    Salwender, Hans
    Scheid, Christof
    Graeven, Ullrich
    Peceny, Rudolf
    Staib, Peter
    Dieing, Annette
    Einsele, Hermann
    Jauch, Anna
    Hundemer, Michael
    Zago, Manola
    Pozek, Ema
    Benner, Axel
    Bokemeyer, Carsten
    Goldschmidt, Hartmut
    Weisel, Katja C.
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (01) : 26 - +
  • [49] Bortezomib, lenalidomide and dexamethasone (VRd) vs carfilzomib, lenalidomide and dexamethasone (KRd) as induction therapy in newly diagnosed multiple myeloma
    Tan, Carlyn Rose
    Derkach, Andriy
    Nemirovsky, David
    Ciardiello, Amanda
    Diamond, Benjamin
    Hultcrantz, Malin
    Hassoun, Hani
    Mailankody, Sham
    Shah, Urvi
    Maclachlan, Kylee
    Patel, Dhwani
    Lahoud, Oscar B. B.
    Landau, Heather J. J.
    Chung, David J. J.
    Shah, Gunjan L. L.
    Scordo, Michael
    Giralt, Sergio A. A.
    Lesokhin, Alexander
    Usmani, Saad Z. Z.
    Landgren, Ola
    Korde, Neha
    BLOOD CANCER JOURNAL, 2023, 13 (01)
  • [50] Bortezomib, lenalidomide and dexamethasone (VRd) vs carfilzomib, lenalidomide and dexamethasone (KRd) as induction therapy in newly diagnosed multiple myeloma
    Carlyn Rose Tan
    Andriy Derkach
    David Nemirovsky
    Amanda Ciardiello
    Benjamin Diamond
    Malin Hultcrantz
    Hani Hassoun
    Sham Mailankody
    Urvi Shah
    Kylee Maclachlan
    Dhwani Patel
    Oscar B. Lahoud
    Heather J. Landau
    David J. Chung
    Gunjan L. Shah
    Michael Scordo
    Sergio A. Giralt
    Alexander Lesokhin
    Saad Z. Usmani
    Ola Landgren
    Neha Korde
    Blood Cancer Journal, 13
12345